Management of infusion reactions associated with cetuximab treatment: A case report

Cetuximab is a drug targeting the epidermal growth factor receptor, which is indicated for the treatment of unresectable advanced or recurrent head and neck or colorectal cancer. Cetuximab also enhances the cytotoxic effects of radiation in squamous cell carcinoma. The severity of infusion reactions...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohshita, Naohiro, Ichimaru, Yuri, Gamoh, Shoko, Tsuji, Kaname, Kishimoto, Naotaka, Tsutsumi, Yasuo M., Momota, Yoshihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5451859/
https://www.ncbi.nlm.nih.gov/pubmed/28588776
http://dx.doi.org/10.3892/mco.2017.1242

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5451859/
https://www.ncbi.nlm.nih.gov/pubmed/28588776
http://dx.doi.org/10.3892/mco.2017.1242

Ejemplares similares